Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates

ABSTRACT Shiga toxin (Stx)-producing Escherichia coli (STEC) strains of serogroup O91 are the most common human pathogenic eae-negative STEC strains. To facilitate diagnosis and subtyping of these pathogens, we genotypically and phenotypically characterized 100 clinical STEC O91 isolates. Motile strains expressed flagellar antigens H8 (1 strain), H10 (2 strains), H14 (52 strains), and H21 (20 strains) or were H nontypeable (Hnt) (10 strains); 15 strains were nonmotile. All nonmotile and Hnt strains possessed the fliC gene encoding the flagellin subunit of the H14 antigen (fliCH14). Most STEC O91 strains possessed enterohemorrhagic E. colihlyA and expressed an enterohemolytic phenotype. Among seven stx alleles identified, stx2dact, encoding mucus- and elastase-activatable Stx2d, was present solely in STEC O91:H21, whereas most strains of the other serotypes possessed stx1. Moreover, only STEC O91:H21 possessed the cdt-V cluster, encoding cytolethal distending toxin V; the toxin was regularly expressed and was lethal to human microvascular endothelial cells. Infection with STEC O91:H21 was associated with hemolytic-uremic syndrome (P = 0.0015), whereas strains of the other serotypes originated mostly in patients with nonbloody diarrhea. We conclude that STEC O91 clinical isolates belong to at least four lineages that differ by H antigens/fliC types, stx genotypes, and non-stx putative virulence factors, with accumulation of virulence determinants in the O91:H21 lineage. Isolation of STEC O91 from patients' stools on enterohemolysin agar and the rapid initial subtyping of these isolates using fliC genotyping facilitate the identification of these emerging pathogens in clinical and epidemiological studies and enable prediction of the risk of a severe clinical outcome.

[1]  H. Karch,et al.  Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin , 2009, Molecular microbiology.

[2]  L. Beutin,et al.  Shiga Toxin–producing Escherichia coli Serogroups in Food and Patients, Germany , 2008, Emerging infectious diseases.

[3]  A. Mellmann,et al.  Detection and Characterization of the Fimbrial sfp Cluster in Enterohemorrhagic Escherichia coli O165:H25/NM Isolates from Humans and Cattle , 2008, Applied and Environmental Microbiology.

[4]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[5]  Shaohua Zhao,et al.  Identification and Characterization of Shiga Toxin Type 2 Variants in Escherichia coli Isolates from Animals, Food, and Humans , 2008, Applied and Environmental Microbiology.

[6]  N. Pradel,et al.  Molecular Analysis of Shiga Toxin-Producing Escherichia coli Strains Isolated from Hemolytic-Uremic Syndrome Patients and Dairy Samples in France , 2008, Applied and Environmental Microbiology.

[7]  K. Seto,et al.  Biochemical and molecular characterization of minor serogroups of Shiga toxin-producing Escherichia coli isolated from humans in Osaka prefecture. , 2007, The Journal of veterinary medical science.

[8]  A. Mellmann,et al.  Subtypes of the Plasmid-Encoded Serine Protease EspP in Shiga Toxin-Producing Escherichia coli: Distribution, Secretion, and Proteolytic Activity , 2007, Applied and Environmental Microbiology.

[9]  M. Dierich,et al.  Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. , 2007, Research in microbiology.

[10]  A. Mellmann,et al.  Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. , 2007, International journal of medical microbiology : IJMM.

[11]  K. Bettelheim.  The Non-O157 Shiga-Toxigenic (Verocytotoxigenic) Escherichia coli; Under-Rated Pathogens , 2007, Critical reviews in microbiology.

[12]  L. Kreienbrock,et al.  Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. , 2006, American journal of epidemiology.

[13]  L. Beutin,et al.  Identification of Sequence Diversity in the Escherichia coli fliC Genes Encoding Flagellar Types H8 and H40 and Its Use in Typing of Shiga Toxin-Producing E. coli O8, O22, O111, O174, and O179 Strains , 2006, Journal of Clinical Microbiology.

[14]  A. Friedrich,et al.  Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Hagedorn,et al.  Rapid Identification and Differentiation of Clinical Isolates of Enteropathogenic Escherichia coli (EPEC), Atypical EPEC, and Shiga Toxin-Producing Escherichia coli by a One-Step Multiplex PCR Method , 2006, Journal of Clinical Microbiology.

[16]  A. Friedrich,et al.  Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.

[17]  P. Griffin,et al.  Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. , 2006, Foodborne pathogens and disease.

[18]  J. Wells,et al.  Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. , 2005, The Journal of infectious diseases.

[19]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[20]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  H. Karch,et al.  Molecular Profiling and Phenotype Analysis of Escherichia coli O26:H11 and O26:NM: Secular and Geographic Consistency of Enterohemorrhagic and Enteropathogenic Isolates , 2005, Journal of Clinical Microbiology.

[22]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[23]  H. Karch,et al.  Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.

[24]  S. Iyoda,et al.  Distribution of Putative Adhesins in Different Seropathotypes of Shiga Toxin-Producing Escherichia coli , 2004, Journal of Clinical Microbiology.

[25]  A. Mellmann,et al.  Phylogeny, Clinical Associations, and Diagnostic Utility of the Pilin Subunit Gene (sfpA) of Sorbitol-Fermenting, Enterohemorrhagic Escherichia coli O157:H− , 2004, Journal of Clinical Microbiology.

[26]  P. Srimanote,et al.  A New Family of Potent AB5 Cytotoxins Produced by Shiga Toxigenic Escherichia coli , 2004, The Journal of experimental medicine.

[27]  P. Fach,et al.  Detection by 5'-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world's most frequent clinical cases. , 2004, Molecular and cellular probes.

[28]  H. Karch,et al.  Characterization of Cytolethal Distending Toxin Genes and Expression in Shiga Toxin-Producing Escherichia coli Strains of Non-O157 Serogroups , 2004, Infection and Immunity.

[29]  H. Karch,et al.  Phenotypic and Genotypic Analyses of Enterohemorrhagic Escherichia coli O145 Strains from Patients in Germany , 2004, Journal of Clinical Microbiology.

[30]  Gtacggactaacagggaactg,et al.  A New Family of Potent AB 5 Cytotoxins Produced by Shiga Toxigenic Escherichia coli , 2004 .

[31]  F. Gunzer,et al.  Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens , 2003, Journal of Clinical Microbiology.

[32]  P. Desmarchelier,et al.  Presence of Activatable Shiga Toxin Genotype (stx2d) in Shiga Toxigenic Escherichia coli from Livestock Sources , 2003, Journal of Clinical Microbiology.

[33]  H. Karch,et al.  Cytolethal Distending Toxin Gene Cluster in Enterohemorrhagic Escherichiacoli O157:H− and O157:H7: Characterization and Evolutionary Considerations , 2003, Infection and Immunity.

[34]  A. Friedrich,et al.  Shiga Toxin 1c-Producing Escherichia coli Strains: Phenotypic and Genetic Characterization and Association with Human Disease , 2003, Journal of Clinical Microbiology.

[35]  A. Fruth,et al.  Subtyping of pathogenic Escherichia coli strains using flagellar (H)-antigens: serotyping versus fliC polymorphisms. , 2003, International journal of medical microbiology : IJMM.

[36]  R. Robins-Browne,et al.  Identification of a Novel Fimbrial Gene Cluster Related to Long Polar Fimbriae in Locus of Enterocyte Effacement-Negative Strains of Enterohemorrhagic Escherichia coli , 2002, Infection and Immunity.

[37]  L. Teel,et al.  One of Two Copies of the Gene for the Activatable Shiga Toxin Type 2d in Escherichia coli O91:H21 Strain B2F1 Is Associated with an Inducible Bacteriophage , 2002, Infection and Immunity.

[38]  D. Tompkins,et al.  Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  A. O’Brien,et al.  Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C‐terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer , 2002, Molecular microbiology.

[40]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[41]  H. Karch,et al.  Identification and Characterization of a Novel Genomic Island Integrated at selC in Locus of Enterocyte Effacement-Negative, Shiga Toxin-Producing Escherichia coli , 2001, Infection and Immunity.

[42]  P. Srimanote,et al.  Characterization of Saa, a Novel Autoagglutinating Adhesin Produced by Locus of Enterocyte Effacement-Negative Shiga-ToxigenicEscherichia coli Strains That Are Virulent for Humans , 2001, Infection and Immunity.

[43]  A. Siitonen,et al.  Clinical Isolates of Non-O157 Shiga Toxin-ProducingEscherichia coli: Serotypes, Virulence Characteristics, and Molecular Profiles of Strains of the Same Serotype , 2001, Journal of Clinical Microbiology.

[44]  T. R. Ward,et al.  Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure , 2000, Infection and Immunity.

[45]  A. O’Brien,et al.  Elastase in Intestinal Mucus Enhances the Cytotoxicity of Shiga Toxin Type 2d* , 2000, The Journal of Biological Chemistry.

[46]  S. Lauwers,et al.  Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.

[47]  B. Souweine,et al.  Non-O157:H7 Stx2-Producing Escherichia coli Strains Associated with Sporadic Cases of Hemolytic-Uremic Syndrome in Adults , 1998, Journal of Clinical Microbiology.

[48]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[49]  B. Swaminathan,et al.  Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM , 1997, Journal of clinical microbiology.

[50]  A. O’Brien,et al.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice , 1996, Infection and immunity.

[51]  H. Lior,et al.  A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. , 1988, Microbial pathogenesis.